Muhammad Amer1, Rehan Qayyum. 1. Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21287.
Abstract
CONTEXT: Hyperhomocysteinemia is an independent risk factor for premature atherosclerosis and thromboembolism. 25-Hydroxyvitamin D [25(OH)D] may modulate the expression of genes involved in homocysteine metabolism. OBJECTIVE: Little is known about the relationship between homocysteine and 25(OH)D. We hypothesized an inverse and nonlinear association between 25(OH)D and homocysteine. DESIGN: We analyzed data from the continuous National Health and Nutrition Examination Survey 2001-2006 for asymptomatic adults (≥18 y). SETTING: Linear regression models with spline adjusted for cardiovascular disease risk factors were used to explore nonlinearity. MAIN OUTCOMES MEASURE: Mean change (β-coefficients with 95% confidence intervals) in homocysteine was reported per 10 ng/mL change in 25(OH)D. RESULTS: Mean (SD) age and homocysteine levels of 14 630 participants were 47.2 (20) years and 8.8 (4.7) μmol/L, respectively, whereas the median (interquartile range) of 25(OH)D was 21 (15-27) ng/mL. Without using spline, we observed an inverse relation between homocysteine and 25(OH)D both in simple [-0.25 (-0.34 to -0.02) μmol/L] and multivariable [-0.13 (-0.18 to -0.01) μmol/L] regression. With spline, in a univariate model, an increase in 25(OH)D was associated with a significant decrease in homocysteine [-0.56 (-0.75 to -0.37) μmol/L] until 25(OH)D reaches but not if above its median (21 ng/mL). Similarly, in multivariable spline models, the inverse relationship between homocysteine and 25(OH)D remain significant [-0.49 (-0.67 to -0.31) μmol/L] only below the population median of 25(OH)D. CONCLUSIONS: From a large community-based cohort of asymptomatic adults, we found an inverse relation between 25(OH)D and homocysteine among those with 25(OH)D concentration of 21 ng/mL or less. We did not observe any statistical decrease in homocysteine once 25(OH)D concentration rose above 21 ng/mL.
CONTEXT: Hyperhomocysteinemia is an independent risk factor for premature atherosclerosis and thromboembolism. 25-Hydroxyvitamin D [25(OH)D] may modulate the expression of genes involved in homocysteine metabolism. OBJECTIVE: Little is known about the relationship between homocysteine and 25(OH)D. We hypothesized an inverse and nonlinear association between 25(OH)D and homocysteine. DESIGN: We analyzed data from the continuous National Health and Nutrition Examination Survey 2001-2006 for asymptomatic adults (≥18 y). SETTING: Linear regression models with spline adjusted for cardiovascular disease risk factors were used to explore nonlinearity. MAIN OUTCOMES MEASURE: Mean change (β-coefficients with 95% confidence intervals) in homocysteine was reported per 10 ng/mL change in 25(OH)D. RESULTS: Mean (SD) age and homocysteine levels of 14 630 participants were 47.2 (20) years and 8.8 (4.7) μmol/L, respectively, whereas the median (interquartile range) of 25(OH)D was 21 (15-27) ng/mL. Without using spline, we observed an inverse relation between homocysteine and 25(OH)D both in simple [-0.25 (-0.34 to -0.02) μmol/L] and multivariable [-0.13 (-0.18 to -0.01) μmol/L] regression. With spline, in a univariate model, an increase in 25(OH)D was associated with a significant decrease in homocysteine [-0.56 (-0.75 to -0.37) μmol/L] until 25(OH)D reaches but not if above its median (21 ng/mL). Similarly, in multivariable spline models, the inverse relationship between homocysteine and 25(OH)D remain significant [-0.49 (-0.67 to -0.31) μmol/L] only below the population median of 25(OH)D. CONCLUSIONS: From a large community-based cohort of asymptomatic adults, we found an inverse relation between 25(OH)D and homocysteine among those with 25(OH)D concentration of 21 ng/mL or less. We did not observe any statistical decrease in homocysteine once 25(OH)D concentration rose above 21 ng/mL.
Authors: E G Vermeulen; C D Stehouwer; J W Twisk; M van den Berg; S C de Jong; A J Mackaay; C M van Campen; F C Visser; C A Jakobs; E J Bulterjis; J A Rauwerda Journal: Lancet Date: 2000-02-12 Impact factor: 79.321
Authors: Jaimie D Vaughn; Lynn B Bailey; Karla P Shelnutt; Kristina M von-Castel Dunwoody; David R Maneval; Steven R Davis; Eoin P Quinlivan; Jesse F Gregory; Douglas W Theriaque; Gail P A Kauwell Journal: J Nutr Date: 2004-11 Impact factor: 4.798
Authors: Marc Blondon; Mary Cushman; Nancy Jenny; Erin D Michos; Nicholas L Smith; Bryan Kestenbaum; Ian H de Boer Journal: J Clin Endocrinol Metab Date: 2016-03-29 Impact factor: 5.958
Authors: Charles J Glueck; Vybhav Jetty; Matan Rothschild; Gregory Duhon; Parth Shah; Marloe Prince; Kevin Lee; Michael Goldenberg; Ashwin Kumar; Naila Goldenberg; Ping Wang Journal: N Am J Med Sci Date: 2016-07
Authors: Truong-Minh Pham; John Paul Ekwaru; Silmara S Mastroeni; Marco F Mastroeni; Sarah A Loehr; Paul J Veugelers Journal: PLoS One Date: 2016-08-22 Impact factor: 3.240
Authors: Kamil F Faridi; Joshua R Lupton; Seth S Martin; Maciej Banach; Renato Quispe; Krishnaji Kulkarni; Steven R Jones; Erin D Michos Journal: Arch Med Sci Date: 2017-06-12 Impact factor: 3.318
Authors: Anna Walentukiewicz; Anna Lysak-Radomska; Joanna Jaworska; Krzysztof Prusik; Katarzyna Prusik; Jakub Antoni Kortas; Marcin Lipiński; Anna Babinska; Jedrzej Antosiewicz; Ewa Ziemann Journal: Int J Environ Res Public Health Date: 2018-09-20 Impact factor: 3.390